Enzo Biochem Inc (ENZ)

11.29
NYSE : Health Care
Prev Close 11.29
Day Low/High 0.00 / 0.00
52 Wk Low/High 4.88 / 12.04
Avg Volume 267.80K
Exchange NYSE
Shares Outstanding 46.41M
Market Cap 518.37M
EPS 1.00
P/E Ratio 15.51
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We made no trades during the holiday-shortened week, but added to our natural hedge today.

Disney, Nvidia, Walmart and 12 Other Stocks That Could Skyrocket Going Into 2018

Disney, Nvidia, Walmart and 12 Other Stocks That Could Skyrocket Going Into 2018

From bank stocks to tech, these are my favorite names.

Stocks Under $10 Weekly Summary

We added a name to the portfolio's Bullpen as a whirlwind quarter came to an end.

Enzo Biochem Reports Delaware Court Ruling

Enzo Biochem Reports Delaware Court Ruling

Enzo Biochem Inc. (NYSE:ENZ) reported today that a federal judge for the U.

Stocks Under $10 Weekly Summary

We exited 2 positions and took some profits during a busy week for the portfolio.

Taking Some Profits in Life Science/Biotech Name

We'll sell half of our ENZ position on today's strength.

'Grounding' Aerospace Name; Strategies on 2 Other Positions

We'll exit our tiny stake in AIRI, and look to take some profits in ENZ.

Assessing Some Winners and Losers

We're adding to PXLW, raising our target on ENZ, and prepared to buy more AXAS on weakness.

Stocks Under $10 Weekly Summary

We initiated a new position and made several other trades during a week of twists and turns.

Making a Call to the Bullpen

We'll initiate a small position in Air Industries Group. Plus, an update on Enzo Biochem.

Stocks Under $10 Weekly Summary

We initiated 2 new positions in a week dominated by political events.

Enzo Biochem Reports Increased Revenues, Improved Operating Results

Enzo Biochem Inc. (NYSE:ENZ) today announced growth in operating results for the third fiscal quarter and nine months ended April 30, 2017.

Enzo Biochem Announces New York State Health Department Approval Of New Women's Health Diagnostics

Enzo Biochem, Inc. (NYSE:ENZ) today announced that the New York State Department of Health has granted conditional approval for three additional women's health related molecular diagnostic tests for use with the Company's...

Stocks Under $10 Weekly Summary

We scaled further into one position and added a Bullpen name as the market shrugged off geopolitical uncertainties.

Enzo Biochem Schedules Teleconference To Discuss Third Quarter 2017 Results Friday, June 9, 2017 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2017 third quarter results, Friday, June 9, 2017, at 8:30 AM E.

Stocks Under $10 Weekly Summary

We exited 3 names last week as stocks continued their run.

Stocks Under $10 Weekly Summary

It was a busy week of moves in the portfolio as we head into the latter half of the second quarter.

How to Play Pixelworks and Enzo Biochem

Big moves for both stocks mean we need to modify our positions.

Stocks Under $10 Weekly Summary

We initiated one new position and exited another last week, while several other names reported earnings.

Adding a Life Sciences/Biotech Name

Wading in small on Enzo Biochem.

Commit To Purchase Enzo Biochem At $7.50, Earn 11.9% Annualized Using Options

Investors considering a purchase of Enzo Biochem, Inc. stock, but tentative about paying the going market price of $8.69/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Enzo Biochem's Clinical Laboratory Named An In-Network Provider To The Fourth Largest National Insurer

Enzo Biochem, Inc. (NYSE:ENZ) announced today that its Enzo Clinical Laboratory subsidiary, a full-service clinical laboratory with a specialty in women's health, today reached an agreement with the nation's fourth largest...

Enzo Biochem Reports Increased Second Quarter Operating Results

Enzo Biochem, Inc. (NYSE:ENZ) today reported continued strong growth in operating results for the fiscal quarter and six months ended January 31, 2017.

Enzo Biochem Re-Schedules Teleconference To Discuss Second Quarter 2017 Results For This Afternoon, Monday, March 13, 2017 At 4:30 PM E.D.T. Due To Impending Storm

Enzo Biochem, Inc. (NYSE:ENZ), has rescheduled its planned conference call to discuss fiscal 2017 second quarter results for this afternoon, Monday, March 13, 2017, at 4:30 PM E.

Enzo Biochem Schedules Teleconference To Discuss Second Quarter 2017 Results Tuesday, March 14, 2017 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2017 second quarter results, Tuesday, March 14, 2017, at 8:30 AM E.

Enzo Biochem Reports Improved First Quarter Results

Enzo Biochem Reports Improved First Quarter Results

Enzo Biochem, Inc. (NYSE:ENZ) today reported strong operating results for the first fiscal quarter ended October 31, 2016, with significant operating profit achieved at Enzo Clinical Labs.

Enzo Biochem Schedules Teleconference To Discuss First Quarter 2017 Results Friday, December 9, 2016 At 8:30 AM E.T.

Enzo Biochem Schedules Teleconference To Discuss First Quarter 2017 Results Friday, December 9, 2016 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2017 first quarter results, Friday, December 9, 2016, at 8:30 AM E.